.jpg "Daniel M. Freed, PhD photo")
Chief Scientific Officer
Chordoma Foundation
Dan has 20 years of experience in cancer biology, translational research, and preclinical drug development spanning the academic and biopharmaceutical arenas, including expertise in understanding how the internal ‘wiring’ of cells changes during tumor development and progression. At the Chordoma Foundation, Dan works to identify therapeutically actionable vulnerabilities in chordoma to provide rationale for new clinical trials. Throughout his career, Dan has been a strong advocate of approaching biomedical questions using a variety of approaches at different resolutions, and is working to bring a comprehensive “molecules-to-patients” philosophy to chordoma to identify new treatment options for those afflicted by this disease. Dan received his PhD from the University of Virginia, followed by postdoctoral training at Penn Medicine and the Yale Cancer Biology Institute.
